Vitexicarpin Acts as a Novel Angiogenesis Inhibitor and Its Target Network
Authors:
Open Access
- 12 February 2013
- journal article
- research article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2013, 1-13
Abstract
Vitexicarpin (VIT) isolated from the fruits ofVitex rotundifoliahas shown antitumor, anti-inflammatory, and immunoregulatory properties. This work is designed to evaluate the antiangiogenic effects of VIT and address the underlying action mechanism of VIT by a network pharmacology approach. The results validated that VIT can act as a novel angiogenesis inhibitor. Firstly, VIT can exert good antiangiogenic effects by inhibiting vascular-endothelial-growth-factor- (VEGF-) induced endothelial cell proliferation, migration, and capillary-like tube formation on matrigel in a dose-dependent manner. Secondly, VIT was also shown to have an antiangiogenic mechanism through inhibition of cell cycle progression and induction of apoptosis. Thirdly, VIT inhibited chorioallantoic membrane angiogenesis as well as tumor angiogenesis in an allograft mouse tumor model. We further addressed VIT’s molecular mechanism of antiangiogenic actions using one of our network pharmacology methods named drugCIPHER. Then, we tested some key molecules in the VEGF pathway targeted by VIT and verified the inhibition effects of VIT on AKT and SRC phosphorylation. Taken together, this work not only identifies VIT as a novel potent angiogenesis inhibitor, but also demonstrates that network pharmacology methods can be an effective and promising approach to make discovery and understand the action mechanism of herbal ingredients.Keywords
Funding Information
- National Natural Science Foundation of China (81225025, 60934004, 61021063)
- National Natural Science Foundation of China (81225025, 60934004, 61021063)
- National Natural Science Foundation of China (81225025, 60934004, 61021063)
- China Academy of Traditional Chinese Medicine (81225025, 60934004, 61021063)
This publication has 54 references indexed in Scilit:
- Allo-network drugs: harnessing allostery in cellular networksTrends in Pharmacological Sciences, 2011
- PubChem promiscuity: a web resource for gathering compound promiscuity data from PubChemBioinformatics, 2011
- Network medicine: a network-based approach to human diseaseNature Reviews Genetics, 2010
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- Human Protein Reference Database--2009 updateNucleic Acids Research, 2008
- Network‐based global inference of human disease genesMolecular Systems Biology, 2008
- DrugBank: a knowledgebase for drugs, drug actions and drug targetsNucleic Acids Research, 2007
- Molecular Understanding and Modern Application of Traditional Medicines: Triumphs and TrialsCell, 2007
- Angiogenesis in life, disease and medicineNature, 2005
- BIND: the Biomolecular Interaction Network DatabaseNucleic Acids Research, 2003